Patents by Inventor Kamal D. Moudgil

Kamal D. Moudgil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders
    Patent number: 11766403
    Abstract: The present invention relates in part to compositions for targeted delivery of an agent and agent delivery systems comprising a novel tissue-targeting peptide ligand (CKPFDRALC) (SEQ ID NO: 1) named ART-2. In certain aspects, the ART-2-coated liposomes encapsulating an agent, such as a therapeutic agent, diagnostic agent, imaging agent, or any combination thereof, were more effective in inhibiting, diagnosing, or imaging a disease or disorder, such as an arthritis progression, than control, despite a comparable safety profile.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: September 26, 2023
    Assignees: University of Maryland, Baltimore, The United States Government as represented by the Department of Veterans Affairs
    Inventors: Kamal D. Moudgil, Rakeshchandra R. Meka
  • PEPTIDE-TARGETED LIPOSOMAL DELIVERY FOR TREATMENT, DIAGNOSIS, AND IMAGING OF DISEASES AND DISORDERS
    Publication number: 20200297633
    Abstract: The present invention relates in part to compositions for targeted delivery of an agent and agent delivery systems comprising a novel tissue-targeting peptide ligand (CKPFDRALC) named ART-2. In certain aspects, the ART-2-coated liposomes encapsulating an agent, such as a therapeutic agent, diagnostic agent, imaging agent, or any combination thereof, were more effective in inhibiting, diagnosing, or imaging a disease or disorder, such as an arthritis progression, than control, despite a comparable safety profile.
    Type: Application
    Filed: March 20, 2020
    Publication date: September 24, 2020
    Inventors: Kamal D. Moudgil, Rakeshchandra R. Meka